Compare · KAVL vs RCM
KAVL vs RCM
Side-by-side comparison of Kaival Brands Innovations Group Inc. (KAVL) and R1 RCM Inc. (RCM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both KAVL and RCM operate in Other Consumer Services (Consumer Discretionary), so they compete in similar markets.
- RCM is the larger of the two at $6.21B, about 390.8x KAVL ($15.9M).
- RCM has more recent analyst coverage (25 ratings vs 0 for KAVL).
- Company
- Kaival Brands Innovations Group Inc.
- R1 RCM Inc.
- Price
- $0.13-8.97%
- $14.32+0.07%
- Market cap
- $15.9M
- $6.21B
- 1M return
- +0.00%
- -
- 1Y return
- -76.91%
- -
- Industry
- Other Consumer Services
- Other Consumer Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 25
Kaival Brands Innovations Group Inc.
Kaival Brands Innovations Group, Inc. distributes electronic nicotine delivery systems (ENDS Products) and related components in the Unites States. The company offers Bidi Stick, a disposable and tamper-resistant ENDS Product in various flavor options; and Bidi Pouch, a tobacco-free nicotine formulation, which contains natural fibers and a chew-base filler in different flavors. It sells its products to retail and non-retail customers through website bidivapor.com. The company was formerly known as Quick Start Holdings, Inc. and changed its name to Kaival Brands Innovations Group, Inc. in July 2019. The company is based in Grant-Valkaria, Florida. Kaival Brands Innovations Group, Inc. is a subsidiary of Kaival Holdings, LLC.
R1 RCM Inc.
R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers. It also provides modular services comprising physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. It serves healthcare providers, including health systems, hospitals, and physician groups. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was incorporated in 2003 and is headquartered in Chicago, Illinois.
Latest KAVL
- SEC Form 4 filed by Morris Eric
- SEC Form 4 filed by Mosser Eric
- SEC Form 4 filed by Thoenes Mark L
- Kaival Brands Innovations Group Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 10-Q filed by Kaival Brands Innovations Group Inc.
- Kaival Brands Innovations Group Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- SEC Form 10-K filed by Kaival Brands Innovations Group Inc.
- Kaival Brands Innovations Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form DEFR14A filed by Kaival Brands Innovations Group Inc.
- SEC Form DEF 14A filed by Kaival Brands Innovations Group Inc.
Latest RCM
- Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.
- Director New Mountain Capital, L.L.C. disposed of $1,944,593,908 worth of shares (135,985,588 units at $14.30) (SEC Form 4)
- Director Dill David M returned $708,165 worth of shares to the company (49,522 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- Director Henneman John B Iii returned $1,255,040 worth of shares to the company (87,765 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Director Ashdown Clay
- SEC Form 4 filed by Director Wexler Erik G.
- SEC Form 4 filed by Director Nakis Dominic
- Director Bundy Scanlan Agnes returned $472,100 worth of shares to the company (33,014 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- Director Flanagan Joseph Gerard was granted 98,238 shares and returned $49,840,920 worth of shares to the company (3,485,379 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- President Sparby John M. was granted 332,323 shares and returned $9,154,731 worth of shares to the company (640,191 units at $14.30), closing all direct ownership in the company (SEC Form 4)